BioProcess International

BioProcess International provides the biotechnology industry with peer-reviewed editorial necessary to successfully drive products through the biopharmaceutical, biovaccine and biodiagnostic development process. Our BPA audited circulation consists of 30,010 managers working in all phases of the biotherapeutic development in the US, Europe and Canada. Visit our website to learn more about us www.bioprocessintl.com.

Connexon Creative’s mission is to accelerate science and facilitate science communication by providing free, weekly science newsletters that enhance the way scientific and medical professionals are informed of recent findings, science news and exciting advances in specific areas of immunology and cell biology research. Our expert editorial team stays on top of the scientific literature, continuously seeking out the most current, relevant immunology and cell biology publications and press releases. This information is compiled into 17 free, weekly science newsletters, which have over 60,000 subscriptions globally.

Our publications are highly valued among academic scientists as well as medical professionals and researchers within the biotech and pharma industries, who say they appreciate the time savings that result from having free access to the top research and science news that matters to them. Connexon also shares the top recent science news and other relevant information and resources through our 16 Twitter accounts, which are followed by more than 19,000 academics, medical professionals, institutions, scientific journals and science communication enthusiasts. Follow the Connexon Twitter accounts today to connect with your field!

genetherapynetbanner234x60 - gif

Gene Therapy Net is the information resource for basic and clinical research in gene therapy, and the site serves as a network in the exchange of gene therapy information and breaking news items. Visitors can keep track of the latest scientific papers, conference announcements, gene therapy jobs, regulations and guidelines.

Human Gene Therapy is the premier, multidisciplinary journal covering all aspects of gene therapy. The Journal publishes in-depth coverage of DNA, RNA, and cell therapies by delivering the latest breakthroughs in research and technologies. Human Gene Therapy provides a central forum for scientific and clinical information, including ethical, legal, regulatory, social, and commercial issues, which enables the advancement and progress of therapeutic procedures leading to improved patient outcomes, and ultimately, to curing diseases.
The Journal is divided into three parts. Human Gene Therapy, the flagship, is published 12 times per year. HGT Methods, a bimonthly journal, focuses on the applications of gene therapy to product testing and development. HGT Clinical Development, a quarterly journal, serves as a venue for publishing data relevant to the regulatory review and commercial development of cell and gene therapy products.

HumanImmunologyNews

Connexon Creative’s mission is to accelerate science and facilitate science communication by providing free, weekly science newsletters that enhance the way scientific and medical professionals are informed of recent findings, science news and exciting advances in specific areas of immunology and cell biology research. Our expert editorial team stays on top of the scientific literature, continuously seeking out the most current, relevant immunology and cell biology publications and press releases. This information is compiled into 17 free, weekly science newsletters, which have over 60,000 subscriptions globally.

Connexon Creative’s mission is to accelerate science and facilitate science communication by providing free, weekly science newsletters that enhance the way scientific and medical professionals are informed of recent findings, science news and exciting advances in specific areas of immunology and cell biology research. Our expert editorial team stays on top of the scientific literature, continuously seeking out the most current, relevant immunology and cell biology publications and press releases. This information is compiled into 17 free, weekly science newsletters, which have over 60,000 subscriptions globally.

Immunotherapy is aimed at clinicians and researchers with an interest in therapeutics that harness the immune system to combat disease. The journal is unique in offering readers one place where they can read about immune-based treatments that cover all forms of disease, offering equal spread of content across these disciplines.

MNT Logo 2016

Medical News Today is the largest independent medical and health news site on the web – with 10,000,000 monthly unique users it is ranked number one for medical news on all major search engines. Medical News Today is used by pharmaceutical, biotech and health organizations, advertising agencies, PR companies and vertical ad networks to deliver targeted campaigns to HCPs, patients and caregivers. To find out how Medical News Today can help you to reach the right audience contact peter@medicalnewstoday.com or visit www.medicalnewstoday.com.

.

Drug Target Review is Europe’s leading quarterly magazine for the drug discovery industry. Each issue features peer-written reviews that are submitted exclusively for the magazine by the world’s most respected scientists in their field. Drug Target Review’s key audience includes senior managers and key decision-makers in the pharmaceutical, life science and drug discovery industries at the top pharmaceutical companies and academics and scientists from the top research institutes across the globe. Drug Target Review is the gateway to Europe for anyone looking to do business in the drug discovery industry in Europe.